Phys Vivas · dermatological
Skin Signs of Internal Malignancy — Viva Defence
DCE viva defence for Skin Signs of Internal Malignancy.
On this page
Study tools
Target exams
Skin Signs of Internal Malignancy Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Skin Signs of Internal Malignancy. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
References4ShowHide
- [1]Alsheyyab J, Al-Mahasneh HA, Al-Khalaileh SY, Hasan HA, et al. Pancreatic Adenocarcinoma Presented as Paraneoplastic Dermatomyositis Complicated with Rhabdomyolysis: Case Report and Review Am J Case Rep, 2026.PMID 42397795
- [2]Wick MR, Patterson JW Cutaneous paraneoplastic syndromes Semin Diagn Pathol, 2019.PMID 30736994
- [3]Waldman R, DeWane ME, Lu J Dermatomyositis: Diagnosis and treatment J Am Acad Dermatol, 2020.PMID 31279813
- [4]van Beek AP, de Haas ER, van Vloten WA, et al. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review Eur J Endocrinol, 2004.PMID 15538929